Relief Therapeutics Holding SA (LON:0QKQ)
London
· Delayed Price · Currency is GBP · Price in CHF 3.200
-0.030 (-0.93%)
At close: Feb 21, 2025
Relief Therapeutics Holding Employees
Relief Therapeutics Holding had 49 employees as of December 31, 2023. The number of employees decreased by 20 or -28.99% compared to the previous year.
Employees
49
Change (1Y)
-20
Growth (1Y)
-28.99%
Revenue / Employee
154.51K GBP
Profits / Employee
-830.94K GBP
Market Cap
35.52M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 89,900 |
| GSK plc | 70,212 |
| Haleon | 25,408 |
| Smith & Nephew | 18,452 |
| Hikma Pharmaceuticals | 9,100 |
| ConvaTec Group | 10,136 |
| HUTCHMED (China) | 1,988 |
| Oxford Nanopore Technologies | 1,238 |
Relief Therapeutics Holding News
- 12 days ago - Relief Therapeutics to get European patent for investigational drug RLF‑TD011 - Seeking Alpha
- 12 days ago - Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011 - Accesswire
- 4 weeks ago - Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US - Accesswire
- 2 months ago - Relief Therapeutics advances merger talks with Renexxion - Seeking Alpha
- 2 months ago - Relief Therapeutics Provides Update on Potential Transaction with Renexxion - Accesswire
- 2 months ago - Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial - Accesswire
- 2 months ago - Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations - Accesswire
- 3 months ago - Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa - Accesswire